Nuvigil armodafinil regulatory update

FDA approved CEPH's Nuvigil armodafinil to treat excessive sleepiness associated with narcolepsy, obstructive sleep apnea/hypopnea syndrome and shift work sleep disorder. CEPH plans to launch Nuvigil ...